492 related articles for article (PubMed ID: 29536637)
21. Gilt Vaccination with a Mixed Administration of a PRRS MLV and a PPV1 Subunit Vaccine Protects against Heterologous PRRSV1 Infection and Prevents Detrimental Effects on Piglet Performance.
Garcia-Morante B; Friedrich R; Kaiser T; Kraft C; Bridger P; Noguera M
Viruses; 2020 Jul; 12(8):. PubMed ID: 32717833
[TBL] [Abstract][Full Text] [Related]
22. Antibody response and maternal immunity upon boosting PRRSV-immune sows with experimental farm-specific and commercial PRRSV vaccines.
Geldhof MF; Van Breedam W; De Jong E; Lopez Rodriguez A; Karniychuk UU; Vanhee M; Van Doorsselaere J; Maes D; Nauwynck HJ
Vet Microbiol; 2013 Dec; 167(3-4):260-71. PubMed ID: 24041768
[TBL] [Abstract][Full Text] [Related]
23. Cross-protection of a new type 2 porcine reproductive and respiratory syndrome virus (PRRSV) modified live vaccine (Fostera PRRS) against heterologous type 1 PRRSV challenge in growing pigs.
Park C; Choi K; Jeong J; Chae C
Vet Microbiol; 2015 May; 177(1-2):87-94. PubMed ID: 25769646
[TBL] [Abstract][Full Text] [Related]
24. Intranasal immunization of pigs with porcine reproductive and respiratory syndrome virus-like particles plus 2', 3'-cGAMP VacciGrade™ adjuvant exacerbates viremia after virus challenge.
Van Noort A; Nelsen A; Pillatzki AE; Diel DG; Li F; Nelson E; Wang X
Virol J; 2017 Apr; 14(1):76. PubMed ID: 28403874
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of commercial genotype 1 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine against field isolate of genotype 2 PRRSV.
Ko SS; Seo SW; Sunwoo SY; Yoo SJ; Kim MH; Lyoo YS
Vet Immunol Immunopathol; 2016 Apr; 172():43-9. PubMed ID: 27032502
[TBL] [Abstract][Full Text] [Related]
26. Long-term administration of a commercial porcine reproductive and respiratory syndrome virus (PRRSV)-inactivated vaccine in PRRSV-endemically infected sows.
Papatsiros VG; Alexopoulos C; Kritas SK; Koptopoulos G; Nauwynck HJ; Pensaert MB; Kyriakis SC
J Vet Med B Infect Dis Vet Public Health; 2006 Aug; 53(6):266-72. PubMed ID: 16907957
[TBL] [Abstract][Full Text] [Related]
27. A porcine reproductive and respiratory syndrome virus candidate vaccine based on the synthetic attenuated virus engineering approach is attenuated and effective in protecting against homologous virus challenge.
Evenson D; Gerber PF; Xiao CT; Halbur PG; Wang C; Tian D; Ni YY; Meng XJ; Opriessnig T
Vaccine; 2016 Nov; 34(46):5546-5553. PubMed ID: 27742217
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Two Commercial Type 1 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Modified Live Vaccines against Heterologous Type 1 and Type 2 PRRSV Challenge in Growing Pigs.
Kim T; Park C; Choi K; Jeong J; Kang I; Park SJ; Chae C
Clin Vaccine Immunol; 2015 Jun; 22(6):631-40. PubMed ID: 25855554
[TBL] [Abstract][Full Text] [Related]
29. Effects of two commercial European modified-live vaccines against porcine reproductive and respiratory syndrome viruses in pregnant gilts.
Scortti M; Prieto C; Martínez-Lobo FJ; Simarro I; Castro JM
Vet J; 2006 Nov; 172(3):506-14. PubMed ID: 16169756
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of a modified-live virus vaccine in pigs experimentally infected with a highly pathogenic porcine reproductive and respiratory syndrome virus type 1 (HP-PRRSV-1).
Canelli E; Catella A; Borghetti P; Ferrari L; Ogno G; De Angelis E; Bonilauri P; Guazzetti S; Nardini R; Martelli P
Vet Microbiol; 2018 Nov; 226():89-96. PubMed ID: 30389048
[TBL] [Abstract][Full Text] [Related]
31. Comparative evaluation of 4 commercial modified-live porcine reproductive and respiratory syndrome virus (PRRSV) vaccines against heterologous dual Korean PRRSV-1 and PRRSV-2 challenge.
Oh T; Park SJ; Cho H; Yang S; Ham HJ; Chae C
Vet Med Sci; 2020 Nov; 6(4):846-853. PubMed ID: 32437071
[TBL] [Abstract][Full Text] [Related]
32. A comparison of two commercially available porcine reproductive and respiratory syndrome virus (PRRSV) modified-live virus vaccines analyzing the growth performance in 1-day-old vaccinated swine located on endemic farms co-circulating PRRSV-1 and PRRSV-2.
Yang S; Kang I; Jeong J; Oh T; Park KH; Park SJ; Ham HJ; Jin GR; Lee BH; Chae C
J Vet Med Sci; 2020 Feb; 82(2):224-228. PubMed ID: 31866631
[TBL] [Abstract][Full Text] [Related]
33. Vaccination with a porcine reproductive and respiratory syndrome virus vaccine at 1-day-old improved growth performance of piglets under field conditions.
Jeong J; Kim S; Park KH; Kang I; Park SJ; Yang S; Oh T; Chae C
Vet Microbiol; 2018 Feb; 214():113-124. PubMed ID: 29408022
[TBL] [Abstract][Full Text] [Related]
34. Vaccination against porcine reproductive and respiratory syndrome virus (PRRSV) reduces the magnitude and duration of viremia following challenge with a virulent heterologous field strain.
Calvert JG; Keith ML; Pearce DS; Lenz MC; King VL; Diamondidis YA; Ankenbauer RG; Martinon NC
Vet Microbiol; 2017 Jun; 205():80-83. PubMed ID: 28622868
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of Fostera® PRRS modified live virus (MLV) vaccination strategy against a Thai highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) infection.
Charoenchanikran P; Kedkovid R; Sirisereewan C; Woonwong Y; Arunorat J; Sitthichareonchai P; Sopipan N; Jittimanee S; Kesdangsakonwut S; Thanawongnuwech R
Trop Anim Health Prod; 2016 Oct; 48(7):1351-9. PubMed ID: 27315207
[TBL] [Abstract][Full Text] [Related]
36. Cross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvant.
Dwivedi V; Manickam C; Patterson R; Dodson K; Murtaugh M; Torrelles JB; Schlesinger LS; Renukaradhya GJ
Vaccine; 2011 May; 29(23):4058-66. PubMed ID: 21419162
[TBL] [Abstract][Full Text] [Related]
37. Co-administration of saponin quil A and PRRSV-1 modified-live virus vaccine up-regulates gene expression of type I interferon-regulated gene, type I and II interferon, and inflammatory cytokines and reduces viremia in response to PRRSV-2 challenge.
Charerntantanakul W; Pongjaroenkit S
Vet Immunol Immunopathol; 2018 Nov; 205():24-34. PubMed ID: 30458999
[TBL] [Abstract][Full Text] [Related]
38. Lymphocyte activation as cytokine gene expression and secretion is related to the porcine reproductive and respiratory syndrome virus (PRRSV) isolate after in vitro homologous and heterologous recall of peripheral blood mononuclear cells (PBMC) from pigs vaccinated and exposed to natural infection.
Ferrari L; Martelli P; Saleri R; De Angelis E; Cavalli V; Bresaola M; Benetti M; Borghetti P
Vet Immunol Immunopathol; 2013 Feb; 151(3-4):193-206. PubMed ID: 23228653
[TBL] [Abstract][Full Text] [Related]
39. Comparison of four commercial PRRSV MLV vaccines in herds with co-circulation of PRRSV-1 and PRRSV-2.
Oh T; Kim H; Park KH; Jeong J; Yang S; Kang I; Chae C
Comp Immunol Microbiol Infect Dis; 2019 Apr; 63():66-73. PubMed ID: 30961820
[TBL] [Abstract][Full Text] [Related]
40. An experimental live chimeric porcine circovirus 1-2a vaccine decreases porcine circovirus 2b viremia when administered intramuscularly or orally in a porcine circovirus 2b and porcine reproductive and respiratory syndrome virus dual-challenge model.
Opriessnig T; Gomes-Neto JC; Hemann M; Shen HG; Beach NM; Huang Y; Halbur PG; Meng XJ
Microbiol Immunol; 2011 Dec; 55(12):863-73. PubMed ID: 21951266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
